共 137 条
[1]
Almasbak H(2016)CAR T cell therapy: a game changer in cancer treatment J Immunol Res 2016 5474602-156
[2]
Aarvak T(2021)CAR-T cell therapy: current limitations and potential strategies Blood Cancer J 11 69-199
[3]
Vemuri MC(2019)Engineering and design of chimeric antigen receptors Mol Ther Methods Clin Dev 12 145-1121
[4]
Sterner RC(2018)Universal CARs, universal T cells, and universal CAR T cells J Hematol Oncol 11 132-1365
[5]
Sterner RM(2020)‘Off-the-shelf’ allogeneic CAR T cells: development and challenges Nat Rev Drug Discov 19 185-2797
[6]
Guedan S(2016)Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease J Clin Oncol 34 1112-75
[7]
Calderon H(2018)CAR T cell immunotherapy for human cancer Science 359 1361-5574
[8]
Posey AD(1998)Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product J Immunol 161 2791-56
[9]
Maus MV(2002)Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor Nat Biotechnol 20 70-2544
[10]
Zhao J(2009)A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity J Immunol 183 5563-1342